Literature DB >> 15365752

Initial experience with FSE STIR whole-body MR imaging for staging lymphoma in children.

Christian J Kellenberger1, Stephen F Miller, Mustafa Khan, David L Gilday, Sheila Weitzman, Paul S Babyn.   

Abstract

Our objective was to compare fast spin-echo (FSE) short inversion time inversion recovery (STIR) whole-body MR imaging with standard procedures in staging children with lymphoma. Eight children (age range, 2-16 years) underwent multi-station FSE STIR whole-body MR at initial staging (n=5) or for restaging following completion of therapy (n=5). Whole-body MR and conventional staging procedures, including CT (n=10), gallium-67 scintigraphy (n=9), bone scintigraphy (n=3) and bone marrow biopsy (n=7) were retrospectively compared for detection of sites involved by lymphoma and for the assigned stage. FSE STIR whole-body MR detected more sites of possible lymphomatous involvement at initial staging (87/88) and at restaging (5/5) than did conventional imaging (74/88, 3/5). MR was more sensitive than conventional imaging in detecting bone marrow involvement at initial staging. Following treatment, however, residual and therapy-induced bone marrow signal abnormalities could not be differentiated from lymphomatous involvement. Detection of nodal and visceral involvement correlated well. Our results suggest that FSE STIR whole-body MR imaging is a sensitive technique for evaluating lymphomatous involvement of bone marrow as well as non-marrow sites. Larger prospective trials are needed to determine if FSE STIR whole-body MR can replace standard radiographic procedures for initial staging and contribute in the follow-up of lymphoma in children. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15365752     DOI: 10.1007/s00330-004-2432-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  36 in total

1.  Prognostic importance of magnetic resonance imaging in bone marrow involvement of Hodgkin disease.

Authors:  A Varan; A Cila; M Büyükpamukçu
Journal:  Med Pediatr Oncol       Date:  1999-04

2.  Current concepts in whole-body imaging using turbo short tau inversion recovery MR imaging.

Authors:  G Hargaden; M O'Connell; E Kavanagh; T Powell; R Ward; S Eustace
Journal:  AJR Am J Roentgenol       Date:  2003-01       Impact factor: 3.959

3.  Detection of bone marrow and extramedullary involvement in patients with non-Hodgkin's lymphoma by whole-body MRI: comparison with bone and 67Ga scintigraphies.

Authors:  Masami Iizuka-Mikami; Kiyohisa Nagai; Koji Yoshida; Takashi Sugihara; Yoshimasa Suetsugu; Makoto Mikami; Tsutomu Tamada; Shigeki Imai; Yasumasa Kajihara; Masao Fukunaga
Journal:  Eur Radiol       Date:  2004-02-18       Impact factor: 5.315

4.  MR imaging of lymphomas: impact on therapy.

Authors:  A Greco; A M Jelliffe; E J Maher; A W Leung
Journal:  J Comput Assist Tomogr       Date:  1988 Sep-Oct       Impact factor: 1.826

5.  Comparison of initial lymphoma staging using computed tomography (CT) and magnetic resonance (MR) imaging.

Authors:  B R Hoane; A F Shields; B A Porter; J W Borrow
Journal:  Am J Hematol       Date:  1994-10       Impact factor: 10.047

6.  Clinical and prognostic significance of femoral marrow magnetic resonance imaging in patients with malignant lymphoma.

Authors:  S Tsunoda; S Takagi; O Tanaka; Y Miura
Journal:  Blood       Date:  1997-01-01       Impact factor: 22.113

7.  Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience.

Authors:  R Walker; P Kessar; R Blanchard; M Dimasi; K Harper; V DeCarvalho; E K Yucel; L Patriquin; S Eustace
Journal:  J Magn Reson Imaging       Date:  2000-04       Impact factor: 4.813

8.  Gallium accumulation in marrow lymphocytes.

Authors:  I Boxen
Journal:  Clin Nucl Med       Date:  1999-03       Impact factor: 7.794

9.  Comparison of bone and 67Ga scintigraphy in the initial diagnosis of bone involvement in children with malignant lymphoma.

Authors:  B Mouratidis; D L Gilday; J M Ash
Journal:  Nucl Med Commun       Date:  1994-03       Impact factor: 1.690

10.  MR imaging of infradiaphragmatic lymphadenopathy in children and adolescents with Hodgkin disease: comparison with lymphography and CT.

Authors:  S L Hanna; B D Fletcher; T F Boulden; M M Hudson; C A Greenwald; L E Kun
Journal:  J Magn Reson Imaging       Date:  1993 May-Jun       Impact factor: 4.813

View more
  37 in total

Review 1.  Total-body MR-imaging in oncology.

Authors:  Juergen F Schaefer; Heinz-Peter W Schlemmer
Journal:  Eur Radiol       Date:  2006-04-19       Impact factor: 5.315

2.  Bone involvement in patients with lymphoma: the role of FDG-PET/CT.

Authors:  Niklaus G Schaefer; Klaus Strobel; Christian Taverna; Thomas F Hany
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-09-22       Impact factor: 9.236

Review 3.  Nodal imaging in the neck: recent advances in US, CT and MR imaging of metastatic nodes.

Authors:  Takashi Nakamura; Misa Sumi
Journal:  Eur Radiol       Date:  2007-01-25       Impact factor: 5.315

4.  Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey.

Authors:  Nadir Ghanem; Christian Lohrmann; Monika Engelhardt; Gregor Pache; Markus Uhl; Ulrich Saueressig; Elmar Kotter; Mathias Langer
Journal:  Eur Radiol       Date:  2006-02-04       Impact factor: 5.315

Review 5.  The evolving role of MRI in oncohaematological disorders.

Authors:  O Tamburrini; M A Cova; D Console; P Martingano
Journal:  Radiol Med       Date:  2007-07-24       Impact factor: 3.469

Review 6.  Regional and whole-body imaging in pediatric oncology.

Authors:  Hyun Woo Goo
Journal:  Pediatr Radiol       Date:  2011-04-27

Review 7.  Whole-body diffusion-weighted and proton imaging: a review of this emerging technology for monitoring metastatic cancer.

Authors:  Michael A Jacobs; Li Pan; Katarzyna J Macura
Journal:  Semin Roentgenol       Date:  2009-04       Impact factor: 0.800

8.  Whole-body MRI and PET-CT in the management of cancer patients.

Authors:  Gerwin P Schmidt; Alexander R Haug; Stefan O Schoenberg; Maximilian F Reiser
Journal:  Eur Radiol       Date:  2006-03-15       Impact factor: 5.315

Review 9.  Whole-body diffusion-weighted imaging for staging malignant lymphoma in children.

Authors:  Thomas C Kwee; Taro Takahara; Malou A Vermoolen; Marc B Bierings; Willem P Mali; Rutger A J Nievelstein
Journal:  Pediatr Radiol       Date:  2010-07-30

Review 10.  Whole body MRI and PET/CT in haematological malignancies.

Authors:  Chieh Lin; Alain Luciani; Emmanuel Itti; Corinne Haioun; Alain Rahmouni
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.